Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair follicle transplantation and a 308 nm excimer laser effectively treats perioral vitiligo without unwanted hair growth.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Raltegravir may cause hair loss in some patients.

Use topical treatments for mild acne and oral treatments for moderate to severe acne, avoiding antibiotic monotherapy.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

The guideline provides recommendations for managing alopecia areata effectively.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Some alternative therapies for vitiligo show promise but need more research.

3D imaging effectively tracks skin changes in vitiligo treatment.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

ATP helps prevent skin damage from vandetanib by reducing stress.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Azathioprine may help treat severe alopecia areata, but more research is needed.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.